Mixed fortunes for foreign-invested pharmaceutical firms in Korea
For the immediate future, foreign-invested pharmaceutical firms expect positive growth in Korea's overall pharmaceutical markers, thanks to substantial accumulation of retained earnings for the past years, but market analysts warn that these multinational firms would likely face increased...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
